The article you requested is
Commentary. Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
J Clin Psychiatry 2009;70(6):919-921
Copyright 2009 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
The article in this issue by Hampel et al1 offers a
glimpse of an interesting chapter in the history of Alzheimer’s disease (AD) treatment research. An understanding
of the significance of this report, which touches
on issues ranging from the identification of novel targets
for treatment to widely differing approaches to trial design,
provides an appreciation of the rapid pace of treatment development
in the field and allows one to gain some insight
into an interesting historical sidebar.
Alzheimer’s disease is now the fourth leading cause of
death in people over age 65 years in the United States and
the only major cause of death that is increasing over time.